Related Experiment Video
Updated: Aug 15, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP)
Edgar T Hoorntje1,2, Charlotte Burns3,4,5, Luisa Marsili6,7
1Department of Genetics, University Medical Centre Groningen, University of Groningen (E.T.H., G.J.t.M., J.D.H.J.).
Truncating variants in desmoplakin (DSPtv) cause arrhythmogenic cardiomyopathy. Variant location is a key risk factor for ventricular arrhythmias, guiding precise clinical management.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Epidemiology
Background:
- Truncating variants in desmoplakin (DSPtv) are a significant cause of arrhythmogenic cardiomyopathy.
- The precise genetic architecture and genotype-specific risk factors for DSPtv cardiomyopathy remain incompletely understood.
- This study aimed to evaluate the phenotype, risk factors for ventricular arrhythmias, and underlying genetics of DSPtv cardiomyopathy.
Approach:
- A multi-center international study included probands with DSPtv and cardiac phenotypes, along with gene-positive family members.
- Clinical data, family history, and event-free survival from ventricular arrhythmia were assessed.
- Variant location was compared between cases and controls, with a literature review of reported DSPtv.
Key Points:
- The study analyzed 98 probands and 72 family members, with 146 clinically affected individuals diagnosed with DSPtv.
- Ventricular arrhythmias occurred in 33% of individuals, with DSPtv location and proband status identified as independent risk factors.
- Variants in cases were significantly more likely to occur in regions leading to nonsense-mediated decay of major DSP isoforms compared to controls (83.6% vs 16.4%).
Conclusions:
- Variant location is a novel risk factor for ventricular arrhythmia in DSPtv cardiomyopathy.
- This finding can inform variant interpretation and improve the precision of clinical management for affected individuals.
- The study provides critical insights into the genetic basis and clinical manifestations of DSPtv cardiomyopathy.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy